Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013-01-01 Rimassa, L.; Personeni, N.; Matteo, Simonelli; Santoro, A.
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
2020-01-01 Pinato, David J; Kaneko, Takahiro; Saeed, Anwaar; Pressiani, Tiziana; Kaseb, Ahmed; Wang, Yinghong; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Chieh-Ju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I; Ang, Celina; Marron, Thomas U; Khan, Uqba; Personeni, Nicola; Rimassa, Lorenza; Huang, Yi-Hsiang
Tivantinib for hepatocellular carcinoma
2015-01-01 Rimassa, L; Personeni, N; Santoro, A
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Bozzarelli, Silvia; Personeni, Nicola; Rimassa, Lorenza
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study
2017-01-01 Comito, T.; Cozzi, L.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Tronconi, M.; De Rose, F.; Franceschini, D.; Ascolese, A.; Fogliata, A.; Tomatis, S.; Santoro, A.; Zerbi, A.; Scorsetti, M.
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study
2008-01-01 Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S.
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
2013-01-01 Sclafani, F.; Incarbone, M.; Rimassa, L.; Personeni, N.; Giordano, L.; Alloisio, M.; Santoro, A.
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND)
2019-01-01 Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
2022-01-01 Fulgenzi, Claudia Angela Maria; Cheon, Jaekyung; D'Alessio, Antonio; Nishida, Naoshi; Ang, Celina; Marron, Thomas U; Wu, Linda; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Napolitano, Andrea; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David James
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
2022-01-01 Muhammed, Ambreen; Fulgenzi, Claudia Angela Maria; Dharmapuri, Sirish; Pinter, Matthias; Balcar, Lorenz; Scheiner, Bernhard; Marron, Thomas U; Jun, Tomi; Saeed, Anwaar; Hildebrand, Hannah; Muzaffar, Mahvish; Navaid, Musharraf; Naqash, Abdul Rafeh; Gampa, Anuhya; Ozbek, Umut; Lin, Junk-Yi; Perone, Ylenia; Vincenzi, Bruno; Silletta, Marianna; Pillai, Anjana; Wang, Yinghong; Khan, Uqba; Huang, Yi-Hsiang; Bettinger, Dominik; Abugabal, Yehia I; Kaseb, Ahmed; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza; Nishida, Naoshi; Di Tommaso, Luca; Kudo, Masatoshi; Vogel, Arndt; Mauri, Francesco A; Cortellini, Alessio; Sharma, Rohini; D'Alessio, Antonio; Ang, Celina; Pinato, David J
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
2018-01-01 Vigano, L; Darwish, Ss; Rimassa, L; Cimino, M; Carnaghi, C; Donadon, M; Procopio, F; Personeni, N; Del Fabbro, D; Santoro, A; Torzilli, G
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications
2020-01-01 Masetti, C; Pugliese, N; Messana, G; Ceriani, R; Poretti, D; Lleo, A; Lanza, E; Colombo, M; Personeni, N; Pedicini, V; Torzilli, G; Aghemo, A
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study
2022-01-01 D'Alessio, Antonio; Fulgenzi, Claudia Angela Maria; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Gaillard, Vincent E; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Sharma, Rohini; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
2013-01-01 Sclafani, F; Incarbone, M; Rimassa, L; Personeni, N; Giordano, L; Alloisio, M; Santoro, A
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine
2019-01-01 Rimassa, L; Personeni, N; Aghemo, A; Lleo, A
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
2013-01-01 Personeni, N.; Rimassa, L.; Pressiani, T.; Destro, A.; Ligorio, C.; Tronconi, M. C.; Bozzarelli, S.; Carnaghi, C.; Di Tommaso, L.; Giordano, L.; Roncalli, M.; Santoro, A.
Cabozantinib for the treatment of hepatocellular carcinoma
2019-01-01 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes
2006-01-01 A, Hendlisz; Personeni, N.; T, Delaunoit; S, Debroux; P., Flamen
Tivantinib for hepatocellular carcinoma
2015-01-01 Rimassa, L.; Personeni, N.; Santoro, A.
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?
2018-01-01 Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma | 1-gen-2013 | Rimassa, L.; Personeni, N.; Matteo, Simonelli; Santoro, A. | |
| Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade | 1-gen-2020 | Pinato, David J; Kaneko, Takahiro; Saeed, Anwaar; Pressiani, Tiziana; Kaseb, Ahmed; Wang, Yinghong; Szafron, David; Jun, Tomi; Dharmapuri, Sirish; Naqash, Abdul Rafeh; Muzaffar, Mahvish; Navaid, Musharraf; Lee, Chieh-Ju; Bulumulle, Anushi; Yu, Bo; Paul, Sonal; Nimkar, Neil; Bettinger, Dominik; Hildebrand, Hannah; Abugabal, Yehia I; Ang, Celina; Marron, Thomas U; Khan, Uqba; Personeni, Nicola; Rimassa, Lorenza; Huang, Yi-Hsiang | |
| Tivantinib for hepatocellular carcinoma | 1-gen-2015 | Rimassa, L; Personeni, N; Santoro, A | |
| The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Bozzarelli, Silvia; Personeni, Nicola; Rimassa, Lorenza | |
| Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study | 1-gen-2017 | Comito, T.; Cozzi, L.; Clerici, E.; Franzese, C.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Tronconi, M.; De Rose, F.; Franceschini, D.; Ascolese, A.; Fogliata, A.; Tomatis, S.; Santoro, A.; Zerbi, A.; Scorsetti, M. | |
| Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study | 1-gen-2008 | Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S. | |
| The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer | 1-gen-2013 | Sclafani, F.; Incarbone, M.; Rimassa, L.; Personeni, N.; Giordano, L.; Alloisio, M.; Santoro, A. | |
| Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) | 1-gen-2019 | Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A | |
| Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study | 1-gen-2022 | Fulgenzi, Claudia Angela Maria; Cheon, Jaekyung; D'Alessio, Antonio; Nishida, Naoshi; Ang, Celina; Marron, Thomas U; Wu, Linda; Saeed, Anwaar; Wietharn, Brooke; Cammarota, Antonella; Pressiani, Tiziana; Personeni, Nicola; Pinter, Matthias; Scheiner, Bernhard; Balcar, Lorenz; Napolitano, Andrea; Huang, Yi-Hsiang; Phen, Samuel; Naqash, Abdul Rafeh; Vivaldi, Caterina; Salani, Francesca; Masi, Gianluca; Bettinger, Dominik; Vogel, Arndt; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Galle, Peter R; Kudo, Masatoshi; Rimassa, Lorenza; Singal, Amit G; Sharma, Rohini; Cortellini, Alessio; Gaillard, Vincent E; Chon, Hong Jae; Pinato, David James | |
| The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma | 1-gen-2022 | Muhammed, Ambreen; Fulgenzi, Claudia Angela Maria; Dharmapuri, Sirish; Pinter, Matthias; Balcar, Lorenz; Scheiner, Bernhard; Marron, Thomas U; Jun, Tomi; Saeed, Anwaar; Hildebrand, Hannah; Muzaffar, Mahvish; Navaid, Musharraf; Naqash, Abdul Rafeh; Gampa, Anuhya; Ozbek, Umut; Lin, Junk-Yi; Perone, Ylenia; Vincenzi, Bruno; Silletta, Marianna; Pillai, Anjana; Wang, Yinghong; Khan, Uqba; Huang, Yi-Hsiang; Bettinger, Dominik; Abugabal, Yehia I; Kaseb, Ahmed; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza; Nishida, Naoshi; Di Tommaso, Luca; Kudo, Masatoshi; Vogel, Arndt; Mauri, Francesco A; Cortellini, Alessio; Sharma, Rohini; D'Alessio, Antonio; Ang, Celina; Pinato, David J | |
| Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? | 1-gen-2018 | Vigano, L; Darwish, Ss; Rimassa, L; Cimino, M; Carnaghi, C; Donadon, M; Procopio, F; Personeni, N; Del Fabbro, D; Santoro, A; Torzilli, G | |
| Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications | 1-gen-2020 | Masetti, C; Pugliese, N; Messana, G; Ceriani, R; Poretti, D; Lleo, A; Lanza, E; Colombo, M; Personeni, N; Pedicini, V; Torzilli, G; Aghemo, A | |
| Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study | 1-gen-2022 | D'Alessio, Antonio; Fulgenzi, Claudia Angela Maria; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Gaillard, Vincent E; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Sharma, Rohini; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J | |
| The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer | 1-gen-2013 | Sclafani, F; Incarbone, M; Rimassa, L; Personeni, N; Giordano, L; Alloisio, M; Santoro, A | |
| The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine | 1-gen-2019 | Rimassa, L; Personeni, N; Aghemo, A; Lleo, A | |
| Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma | 1-gen-2013 | Personeni, N.; Rimassa, L.; Pressiani, T.; Destro, A.; Ligorio, C.; Tronconi, M. C.; Bozzarelli, S.; Carnaghi, C.; Di Tommaso, L.; Giordano, L.; Roncalli, M.; Santoro, A. | |
| Cabozantinib for the treatment of hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A | |
| Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes | 1-gen-2006 | A, Hendlisz; Personeni, N.; T, Delaunoit; S, Debroux; P., Flamen | |
| Tivantinib for hepatocellular carcinoma | 1-gen-2015 | Rimassa, L.; Personeni, N.; Santoro, A. | |
| Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity? | 1-gen-2018 | Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71908
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa64
- 2020 - 202616999
- 2010 - 201923026
- 2000 - 200918345
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI972
- Elsevier Ltd761
- Elsevier B.V.651
- MDPI AG497
- Elsevier391
- John Wiley and Sons Inc327
- Springer321
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...299
- Elsevier Inc.264
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS282
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...196
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS180
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2917
- Female1597
- Male1493
- Middle Aged904
- Adult898
- Aged760
- Animals652
- Italy592
- Medicine (all)464
- COVID-19459
Lingua
- eng43532
- ita9129
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58598
- reserved8052
- open3768
- partially open822
- restricted667
- embargoed2
- mixed1